Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Tamoxifen activity against Plasmodium in vitro and in mice
Ada Weinstock
, Julio Gallego-Delgado
, Cláudia Gomes
, Julian Sherman
, Cyrus Nikain
, Sandra Gonzalez
, Edward Fisher
, Ana Rodriguez
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tamoxifen activity against Plasmodium in vitro and in mice'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
4-hydroxytamoxifen
100%
Active Metabolite
100%
Cre-loxP
100%
Plasmodium Falciparum
100%
Plasmodium
100%
Cerebral Malaria
100%
Malaria
66%
Parasitemia
66%
Plasmodium Berghei
66%
Rodents
33%
Gene Expression
33%
Disease Outcome
33%
In Vitro Study
33%
In Vitro Activity
33%
IC50
33%
Early Breast Cancer
33%
Gene Function
33%
LoxP
33%
Breast Reduction
33%
Plasmodium Infection
33%
B6 Mice
33%
Human Parasite
33%
Rodent Malaria
33%
Site-specific Recombination System
33%
Conditional mutant Mice
33%
Estrogen Receptor Modulator
33%
Blood Stage
33%
Plasmodium Berghei ANKA
33%
Immunology and Microbiology
Plasmodium
100%
In Vitro
100%
Metabolite
75%
LoxP Site
75%
Parasitemia
50%
Infection
50%
Gene Expression
25%
Gene Function
25%
IC50
25%
Mouse Mutant
25%
C57BL 6 Mouse
25%
Plasmodium falciparum
25%
Plasmodium berghei
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Plasmodium
100%
Active Metabolite
27%
Afimoxifene
27%
Cerebral Malaria
27%
Infection
18%
Parasitemia
18%
Breast Cancer
9%
Recurrent Disease
9%
IC50
9%
Mouse Mutant
9%
C57BL 6 Mouse
9%
Selective Estrogen Receptor Modulator
9%
Plasmodium berghei
9%
Plasmodium falciparum
9%
Rodent Malaria
9%
Diseases
9%